Bill Text: US HB6227 | 2023-2024 | 118th Congress | Introduced
Bill Title: Adding Coccidioidomycosis to the FDA Priority Review Voucher Program Act of 2023
Spectrum: Slight Partisan Bill (Republican 22-14)
Status: (Introduced) 2023-11-10 - Referred to the Subcommittee on Health. [HB6227 Detail]
Download: US_Congress-2023-HB6227-Introduced.pdf